Menjugate conjugate vaccine: Phase III data

In a U.S. Phase III trial comparing Menjugate to Menomune meningococcal

Read the full 116 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE